Frontage is a CRDMO product development partner for NDA, 505(b)(2), BLA and ANDA submissions, with a CMC portfolio spanning pre-formulation, drug product formulation development, analytical method development and validation, GLP batches, GMP clinical trial materials (Phase I-III manufacturing, labeling, packaging and distribution), scale-up, pilot and pivotal/registration batches, and commercial manufacturing. Its formulation development experience covers dosage forms including oral solids, liquids, sterile injectables, topicals, ophthalmics and nasal products.

No hay comentarios disponibles.
Deja tu valoración & comentario